Bladder Cancer Highlights From ASCO 2024
While there were no practice-changing bladder urothelial carcinoma (UC) data, the 2024 ASCO annual conference yielded practice-informing advances. …
Related Articles
My Attending Told Me to Go to the Gym. He Was Right
“You really need to get to the gym.” My attending yoked upward on the Richardson retractor I was holding. My deltoids were burning and the…
Judge bars Musk’s DOGE team from Social Security records in scathing ruling
A federal judge issued a temporary restraining order barring Elon Musk’s DOGE from accessing personally identifiable information from the Social Security Administration.
Drugs Have Uses We Can’t Imagine. He’s Using A.I. to Find Them.
Scientists are using machine learning to find new treatments among thousands of old medicines.
How I treat patients with AML using azacitidine and venetoclax
Treatment for patients with acute myeloid leukemia (AML) is being transformed for some patients, as targeted agents increase complete remission rates and s
The Peltzman effect and compensatory markers in medicine
Unintended consequences of health care interventions are unavoidable. For example, computerized order entry systems, implemented to reduce prescription errors, catalyze novel errors of their own,…
CTG Labs – NCBI
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair Genes
Germline mutations in DNA repair genes are prevalent in myeloma patients and correlate with duration of response to a frontline genotoxic therapy.
Strategies to promote scholarship among academic hospitalists – PubMed
Academic hospitalists play an integral role in the day-to-day care of hospitalized patients, education and research. They are well-positioned to engage in scholarly and research…
BMA demands new name and clear scope of practice for physician associates
The introduction of physician associate (PA) roles to the NHS has been a ‘total system failure’ that gambles with patient safety, the BMA has warned,…
How I use maintenance therapy in acute myeloid leukemia
Treatment for patients with acute myeloid leukemia (AML) is being transformed for some patients, as targeted agents increase complete remission rates and s